English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [395]
News [1116]
Articles [84]
Editorials [5]
Conferences [73]
elearning [11]
Molecular profiling improves diagnosis and survival for children with high risk cancers
Molecular profiling improves diagnosis and survival for children with high risk cancers
Researchers discover that a type of childhood leukaemia originates during foetal development
Researchers discover that a type of childhood leukaemia originates during foetal development
The use of new technologies expands understanding of brain tumours in children
The use of new technologies expands understanding of brain tumours in children
FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered metastatic thyroid cancer or solid tumours
FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered...
Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy
Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy
Researchers examine implementation of psychosocial support program for adolescents with cancer
Researchers examine implementation of psychosocial support program for adolescents with cancer
Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery
Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Targeting specific protein regions offers a new treatment approach in medulloblastoma
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors
Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors
<1...45678...112>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top